CAR-T 细胞对比双特异性抗体作为三线或后线大 B 细胞淋巴瘤治疗：一项荟萃分析
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis.
64.4分
★★★☆☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 4
复发/难治性滤泡性淋巴瘤的当前免疫治疗策略：双特异性抗体与 CAR-T 细胞疗法
Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T-Cell therapies.
42.5分
★★☆☆☆
站内排序·非疗效
一例复发/难治性弥漫大 B 细胞淋巴瘤患者 CAR-T 细胞治疗后 HIV RNA 的检出：假阳性的可能性与临床意义
Detection of HIV RNA after CAR-T Cell Therapy in A Relapsed/refractory Diffuse Large B-cell Lymphoma Patient: Possibility of False Positivity and Clin
37.6分
★★☆☆☆
站内排序·非疗效
成人成熟 B 细胞淋巴瘤 T 细胞导向免疫治疗的进展：CAR-T 与双特异性抗体治疗的综合综述
Advances in T-Cell-Directed Immunotherapy for Adult Mature B-Cell Lymphoma: A Comprehensive Review of CAR T-Cell and Bispecific Antibody Therapies.
37.6分
★★☆☆☆
站内排序·非疗效
共 4 条